1,106 material Form 8-K filings that 909 companies we cover made with the SEC in June 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Elastic N.V. committed on June 23, 2026 to a plan to reduce its workforce by about 7%, with total non-recurring cash charges of approximately $22 million to $25 million, mostly employee severance, and most of those charges expected in the first quarter of fiscal 2027. Chief Product Officer Ken Exner also resigned, with his last day set for July 17, 2026, and senior engineering leaders will now report to CEO Ashutosh Kulkarni. The filing says total headcount is still expected to grow this fiscal year.
Workforce reduction of approximately 7%; implementation expected to be substantially complete by the end of fiscal Q3 2027
Non-recurring cash charges of approximately $22 million to $25 million, mostly severance and termination benefits
Chief Product Officer Ken Exner resigns effective July 17, 2026; he is leaving for another opportunity, not over a disagreement
Engineering leaders for Elasticsearch and Platform Group and Observability and Security Group will report to CEO Ashutosh Kulkarni
On June 24, 2026, Passage Bio agreed to merge with Remix Therapeutics in an all-stock deal, with the combined company to operate as Remix Therapeutics under the ticker RMTX. Passage shareholders are expected to own about 7% of the combined company, subject to adjustment based on Passage's net cash at closing, and will receive contingent value rights tied to milestones from its out-licensed pediatric gene therapy assets. Closing requires stockholder approvals and a concurrent Remix financing of at least $100 million, and is expected in the fourth quarter of 2026.
Remix has been ascribed an aggregate equity value of $226 million; Passage's equity value is expected to be about $20 million, subject to net cash adjustment.
Remix will complete a concurrent financing of at least $100 million immediately before the merger closes.
Termination payments: $17.5 million from Remix to Passage, or $1.548 million from Passage to Remix, in specified circumstances.
Peter Smith, Ph.D., Remix's co-founder and CEO, will become CEO of the combined company; the merger outside date is December 24, 2026.
MillerKnoll reported fourth-quarter and full fiscal 2026 results for the period ended May 30, 2026, with net sales up 4.4% to $1.004 billion and GAAP diluted EPS of $0.34, compared with a loss of $0.84 a year earlier. Adjusted diluted EPS fell to $0.55 from $0.60, orders declined 6.3%, and Jeff Stutz, Chief Operating Officer, is stepping into the interim CEO role. The company also gave first-quarter and full fiscal 2027 adjusted EPS outlooks of $0.33 to $0.39 and $1.85 to $2.15.
Q4 net sales of $1.004 billion, up 4.4% as reported; orders of $971.5 million, down 6.3%
Q4 GAAP diluted EPS of $0.34 vs. a loss of $0.84 a year earlier; adjusted diluted EPS of $0.55 vs. $0.60
Q1 FY2027 adjusted EPS outlook of $0.33 to $0.39; full year FY2027 outlook of $1.85 to $2.15
Jeff Stutz named incoming interim CEO; company recorded $2.6 million in CEO transition costs in Q4
Crown Crafts reported fourth-quarter fiscal 2026 net income of $0.3 million, or $0.03 per diluted share, compared with a net loss of $10.8 million a year earlier, which included a $13.8 million goodwill impairment charge. Net sales fell to $22.4 million from $23.2 million, and for the full year, net sales were $82.3 million compared with $87.3 million.
Q4 fiscal 2026 net sales $22.4 million vs. $23.2 million; gross margin 22.9% vs. 18.3%
Q4 net income $0.3 million ($0.03 per diluted share) vs. net loss $10.8 million ($1.04 per share) in the prior-year quarter
Full-year fiscal 2026 net income $1.8 million ($0.17 per diluted share) vs. net loss $9.4 million; quarterly dividend of $0.08 per share payable July 2, 2026
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.